AXDX

Accelerate Diagnostics
AXDX

Overview Fund Activity
Delisted

AXDX was delisted on the 14th of May, 2025.

Back to rankings

119 hedge funds and large institutions have $683M invested in Accelerate Diagnostics in 2017 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 51 increasing their positions, 14 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
119
Holders Change
+21
Holders Change %
+21.43%
% of All Funds
2.97%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.15%
New
29
Increased
51
Reduced
14
Closed
8
Calls
$7.96M
Puts
$9.98M
Net Calls
-$2.03M
Net Calls Change
+$2.39M

Top Buyers

1
PC
Polar Capital
United Kingdom
$22M
2
MGM
Miura Global Management
New York
$32.8M
3
CS
Credit Suisse
Switzerland
$24.2M
4
Axa
Axa
France
$8.44M
5
Russell Investments Group
Russell Investments Group
United Kingdom
$7.62M

Top Sellers

1
JPMPWA
J.P. Morgan Private Wealth Advisors
California
$18.3M
2
Nuveen Asset Management
Nuveen Asset Management
Illinois
$18.4M
3
Group One Trading
Group One Trading
Illinois
$0
4
GCP
GSA Capital Partners
United Kingdom
$0
5
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
$18M
Name Holding Trade Value Shares
Change 		Shares
Change %
AIM
126
Arcadia Investment Management
Michigan
– -$16K -65 Closed
NIT
127
NumerixS Investment Technologies
British Columbia, Canada
– -$2K -10 Closed
2 3 4 5
6